PortfoliosLab logo

Talis Biomedical Corporation (TLIS)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$1.00
  • Year Range$0.98 - $12.46
  • EMA (50)$1.36
  • EMA (200)$4.31
  • Average Volume$183.02K
  • Market Capitalization$27.15M

TLISShare Price Chart


Chart placeholderClick Calculate to get results

TLISPerformance

The chart shows the growth of $10,000 invested in Talis Biomedical Corporation on Feb 12, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $625 for a total return of roughly -93.75%. All prices are adjusted for splits and dividends.


TLIS (Talis Biomedical Corporation)
Benchmark (^GSPC)

TLISReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-15.25%-12.57%
YTD-75.06%-18.14%
6M-78.02%-17.07%
1Y-90.33%-5.21%
5Y-88.66%-0.30%
10Y-88.66%-0.30%

TLISMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

TLISSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Talis Biomedical Corporation Sharpe ratio is -1.15. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


TLIS (Talis Biomedical Corporation)
Benchmark (^GSPC)

TLISDividend History


Talis Biomedical Corporation doesn't pay dividends

TLISDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


TLIS (Talis Biomedical Corporation)
Benchmark (^GSPC)

TLISWorst Drawdowns

The table below shows the maximum drawdowns of the Talis Biomedical Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Talis Biomedical Corporation is 96.47%, recorded on May 13, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.47%Feb 16, 2021315May 13, 2022

TLISVolatility Chart

Current Talis Biomedical Corporation volatility is 102.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


TLIS (Talis Biomedical Corporation)
Benchmark (^GSPC)

Portfolios with Talis Biomedical Corporation


Loading data...

More Tools for Talis Biomedical Corporation